Development of an Exergame to Deliver a Sustained Dose of High-Intensity Training
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03477773|
Recruitment Status : Completed
First Posted : March 26, 2018
Last Update Posted : March 26, 2018
|Condition or disease||Intervention/treatment||Phase|
|Metabolic Syndrome||Other: High-intensity exergaming||Not Applicable|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||24 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||Pilot, exploratory, randomized controlled trial|
|Masking:||None (Open Label)|
|Primary Purpose:||Basic Science|
|Official Title:||Development of an Exergame to Deliver a Sustained Dose of High-Intensity Training: Formative Pilot Randomized Trial|
|Actual Study Start Date :||November 1, 2014|
|Actual Primary Completion Date :||April 30, 2015|
|Actual Study Completion Date :||April 30, 2015|
Perform three session of high-intensity, interval training sessions per week over the 6-week intervention
Other: High-intensity exergaming
Perform high-intensity exercise whilst playing a developed exergame. A full warm-up performed prior to the session was performed (~70% HRmax). Periods of exercise were performed at an intensity >85% HRmax for periods of 10, 20 and 30s, interspersed with periods of rest, for a total of 2-3 minutes per session. Heart rate was monitored throughout the intervention.
No Intervention: Control
Continue with their normal habitual lifestyle over the 6-week intervention
- Cardiorespiratory fitness [ Time Frame: Six-weeks ]Predicted VO2max was obtained by performing a submaximal 8-min ramped step test. Heart rate response (Polar T34; PolarElectro OY, Kempele, Finland) and simultaneous breath-by-breath expired gas were collected using a portable indirect calorimeter (Cosmed K4 b2; Rome, Italy), calibrated per the manufacturer's guidelines. Individual HRmax was estimated and plotted against VO2 data for the determination of predicted VO2max (reported in ml.kg.min-1).
- Blood pressure [ Time Frame: Six-weeks ]Blood pressure was collected on the left arm positioned at heart height with the subjects in a seated position by an automatic upper arm blood pressure monitor (Omron MX13). Measures were made at least three times at 3-min intervals, where an average of the two lowest measures was used for analysis (reported in mm/Hg).
- Waist circumference [ Time Frame: Six-weeks ]Waist circumference was measured using the World Health Organization guidelines (reported in cm).
- Body Mass [ Time Frame: Six-weeks ]Body mass was measured using a portable set of electronic scales (Seca, Birmingham, UK) and reported the neasrest 0.1kg.
- Within-participant heart rate [ Time Frame: Six-weeks ]To observe the within-participant heart rate responses to the 10, 20 and 30s high-intensity repetitions across the intervention (reported as percentage of individual heart rate maximum (%).
- Between-participant heart rate [ Time Frame: Six-weeks ]To observe the between-participant heart rate responses to the 10, 20 and 30s high-intensity repetitions across the intervention (reported as percentage of individual heart rate maximum (%).
- Perceptions of the high-intensity exergame [ Time Frame: Six-weeks ]Semistructured interviews were conducted with intervention participants following the 6-week training period to explore the feasability of the intervention and developed exergame
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03477773
|Sheffield Hallam University|
|Sheffield, South Yorkshire, United Kingdom, S102BP|